Literature DB >> 35050701

Prevalence of High-Risk Prostate Cancer Metastasis to Cloquet's Ilioinguinal Lymph Node.

Ana Plata Bello1, Sarah E Apatov2,3, Nicole E Benfante2, Ines Rivero Belenchón4, Natalia Picola Brau5, Claudia Mercader Barrull6, Pocharapong Jenjitranant7,8, Andrew J Vickers9, Samson W Fine10, Karim A Touijer7.   

Abstract

PURPOSE: Cloquet's node, located at the junction between the deep inguinal nodes and the external iliac chain, is easily accessible and commonly excised during pelvic lymph node dissection for prostate cancer. However, we hypothesize that Cloquet's node is not part of lymphatic metastatic spread of prostate cancer.
MATERIALS AND METHODS: Between September 2016 and June 2019, 105 consecutive patients with high-risk prostate cancer (cT3a or Grade Group 4/5, or prostate specific antigen >20 ng/ml) underwent a laparoscopic radical prostatectomy and pelvic lymph node dissection. First, Cloquet's node was identified, retrieved and submitted separately to pathology as right and left Cloquet's node. Next, a pelvic lymph node dissection was completed including the external iliac, obturator fossa and hypogastric nodal packets. Each lymph node was cut into 3 mm slices which were separately embedded in paraffin, stained with hematoxylin and eosin, and examined microscopically.
RESULTS: The final analysis included 95 patients. In this high-risk population, the median number of nodes removed was 22 (IQR 18-29); 39/95 patients (41%) had lymph node metastasis. The median number of Cloquet's nodes removed was 2 (IQR 2-3). Cloquet's node was negative in all but 1 patient (1.1%), who had very high-risk features and high metastatic burden in the lymph nodes.
CONCLUSIONS: In high-risk prostate cancer, metastasis to the ilioinguinal node of Cloquet is rare. Given this low prevalence, Cloquet's node can be safely excluded from the pelvic lymph node dissection template.

Entities:  

Keywords:  inguinal canal; lymph node excision; lymph nodes; lymphatic metastasis; prostatic neoplasms

Mesh:

Year:  2022        PMID: 35050701     DOI: 10.1097/JU.0000000000002439

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.600


  1 in total

1.  The survival benefit of different lymph node yields in radical prostatectomy for pN1M0 prostate cancer patients: Implications from a population-based study.

Authors:  Jieping Hu; Yue Yu; Wei Liu; Jialei Zhong; Xiaochen Zhou; Haibo Xi
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.